APA (7th ed.) Citation

Dimopoulos, M. A., Beksac, M., Pour, L., Delimpasi, S., Vorobyev, V., Quach, H., . . . Opalinska, J. (2024). Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma. New England Journal of Medicine, 391(5), 408. https://doi.org/10.1056/NEJMoa2403407

Chicago Style (17th ed.) Citation

Dimopoulos, Meletios Athanasios, et al. "Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma." New England Journal of Medicine 391, no. 5 (2024): 408. https://doi.org/10.1056/NEJMoa2403407.

MLA (9th ed.) Citation

Dimopoulos, Meletios Athanasios, et al. "Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma." New England Journal of Medicine, vol. 391, no. 5, 2024, p. 408, https://doi.org/10.1056/NEJMoa2403407.